|Slideshows|October 2, 2018
Five Days in Hong Kong: The International Congress of Parkinson Disease and Movement Disorders
Author(s)Natalie Timoshin
You’ll want to get to bed early on Thursday, because you’ll have a very full week ahead. And even if you can't make #MDSCongress, October 5-9, 2018, get your highlights and Editor's Picks here.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1
2
Newer Oral Levodopa Formulations in Parkinson’s Disease
3
Continuous Subcutaneous Infusion Pumps in Parkinson’s Disease
4
Using Subcutaneous Self-Administered Lecanemab for Alzheimer Disease: Robert Przybelski, MD, MS
5







